Return
Company Page
ChronicleBio
Founders
ChronicleBio is a techbio startup that builds an AI-powered drug discovery platform for complex neuroimmune disorders, including POTS, ME/CFS, Long COVID, MCAS, Sjogren's, and Lyme-related illnesses. The company collects rich, longitudinal multimodal biological data, including large-scale patient blood draws, and applies cutting-edge AI models to identify biomarkers, stratify patient subgroups, and accelerate the development of targeted therapeutics for historically overlooked chronic conditions.
Company Founded in 2025
Healthtech & Biotech